Balloon Catheters Market to Reach $5.25B by 2030
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Projected Increase In Market Value Of The Balloon Catheters Market During 2026–2030?
The balloon catheters market has experienced substantial growth in recent years. Its value is anticipated to rise from $4.11 billion in 2025 to $4.32 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.2%. This historical expansion can be ascribed to several factors, including the increasing prevalence of cardiovascular disease, the wider acceptance of angioplasty procedures, the expansion of catheterization laboratories, the availability of sophisticated interventional cardiology devices, and the developing clinical expertise in endovascular treatments.
The balloon catheters market is set for robust expansion over the next few years. It is projected to climb to $5.25 billion by 2030, achieving a compound annual growth rate (CAGR) of 5.0%. This growth during the forecast period is fueled by increasing innovation in balloon catheter coatings, a rising demand for outpatient interventional procedures, the broadening scope of minimally invasive treatment indications, the growing adoption of precision-guided devices, and an escalation in investment in cardiovascular device R&D. Noteworthy trends for the forecast period include the expanding acceptance of drug-eluting balloon catheters, a growing need for minimally invasive cardiovascular procedures, increased utilization of high-pressure and scoring balloons, the diversification of peripheral artery disease treatments, and an enhanced focus on procedural precision and safety.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report
Which Key Factors Are Driving The Balloon Catheters Market Growth?
The expanding use of minimally invasive surgeries is anticipated to drive the expansion of the balloon catheters market in the coming years. Minimally invasive surgeries (MIS) involve surgical operations conducted with tiny incisions, thereby decreasing the need for large cuts or openings. The rise in minimally invasive surgeries (MIS) can be attributed to shorter recovery periods, reduced complication risks, and less pain, alongside advancements in technology and the rise of outpatient procedures. Balloon catheters are vital for amplifying the advantages of minimally invasive surgeries by boosting the accuracy, safety, and patient comfort of procedures, simultaneously shortening recovery periods and hospital stays. As an illustration, Intuitive Surgical Inc., a US-based robotic product manufacturer, disclosed in January 2024 that it had deployed 415 da Vinci surgical systems, which are robotic surgical systems employing a minimally invasive approach, during the fourth quarter of 2023, marking a 12% rise compared to 2022. Consequently, the growing embrace of minimally invasive surgeries fuels the growth within the balloon catheters market.
Which Segment Classifications Are Used In The Balloon Catheters Market Segment Analysis?
The balloon catheters market covered in this report is segmented –
1) By Procedure Type: Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters, Chronic Total Occlusion (CTO) Balloon Catheters
2) By Product Type: Normal Balloon Catheter, Drug Eluting Balloon Catheter, Cutting Balloon Catheter, Stent Graft Balloon Catheter, Scoring Balloon Catheter
3) By Distribution Channel: Direct Tender, Third Party Distribution, Other Distribution Channels
4) By Application: Coronary Artery Disease, Peripheral Artery Disease, Other Applications
5) By End User: Hospitals, Specialty Centers, Ambulatory Surgery Centers, Other End Users
Subsegments:
1) By Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheters: Semi-Compliant Balloon Catheters, Non-Compliant Balloon Catheters
2) By Chronic Total Occlusion (CTO) Balloon Catheters: High-Pressure CTO Balloon Catheters, Low-Profile CTO Balloon Catheters
Which Trends Are Guiding The Direction Of The Balloon Catheters Market?
Major companies in the balloon catheters market are concentrating on developing solutions for mechanical thrombectomy (MT) procedures to optimize the removal of blood clots by managing local blood flow during these interventions. Mechanical thrombectomy (MT) is a minimally invasive medical procedure used for extracting blood clots from blood vessels, typically in instances of ischemic stroke. For example, in September 2024, CERENOVUS, a neurovascular division of Johnson & Johnson Medical Devices Companies, introduced the EMBOGUARD Balloon Guide Catheter in Europe. This device is engineered for endovascular procedures, which include the treatment of acute ischemic stroke. The EMBOGUARD catheter enhances clot removal through localized blood flow control during mechanical thrombectomy procedures. Its implementation has been associated with elevated first-pass recanalization rates, shortened procedure times, and a reduced probability of clot fragments causing distal emboli, which could lead to new ischemic events. The EMBOGUARD Balloon Guide Catheter belongs to the CERENOVUS Stroke Solutions portfolio, a collection of technologies designed to aid physicians in performing mechanical thrombectomy procedures.
Which Firms Are Contributing To The Balloon Catheters Market Ecosystem?
Major companies operating in the balloon catheters market are Cardinal Health Inc., Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Lepu Medical Technology, B. Braun Melsungen AG, Terumo Corporation, Teleflex Incorporated, Cook Medical Inc., Biotronik SE & Co. KG, Merit Medical Systems Inc., Asahi Intecc Co. Ltd., Freudenberg Medical LLC, Biomerics, AngioDynamics Inc., Endologix Inc., Raumedic AG, Otsuka Pharmaceutical Factory Inc., AngioScore Inc., CardioFlow, Endocor GmbH, MicroPort Scientific Corporation, Eureka Medical Inc., Neovasc Inc.
Get The Full Balloon Catheters Market Report:
https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report
Which Region Leads The Balloon Catheters Market In Overall Market Size?
North America was the largest region in the balloon catheters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the balloon catheters market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Balloon Catheters Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/balloon-catheters-global-market-report
Browse Through More Reports Similar to the Global Balloon Catheters Market 2026, By The Business Research Company
Deflectable Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/deflectable-catheters-global-market-report
Pta Balloon Catheter Market Report 2026
https://www.thebusinessresearchcompany.com/report/pta-balloon-catheter-global-market-report
Catheters Market Report 2026
https://www.thebusinessresearchcompany.com/report/catheters-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
